LT2198880T - Kompozicijos, turinčios lipazės, proteazės ir amilazės, skirtos kasos nepakankamumo gydymui - Google Patents

Kompozicijos, turinčios lipazės, proteazės ir amilazės, skirtos kasos nepakankamumo gydymui

Info

Publication number
LT2198880T
LT2198880T LTEP10158639.4T LT10158639T LT2198880T LT 2198880 T LT2198880 T LT 2198880T LT 10158639 T LT10158639 T LT 10158639T LT 2198880 T LT2198880 T LT 2198880T
Authority
LT
Lithuania
Prior art keywords
pancreatic insufficiency
amylase
protease
compositions containing
treating pancreatic
Prior art date
Application number
LTEP10158639.4T
Other languages
English (en)
Inventor
Alexey L. Margolin
Bhami C. Shenoy
Frederick T. Murray
Anthony Christopher Lee Stevens
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of LT2198880T publication Critical patent/LT2198880T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
LTEP10158639.4T 2004-10-14 2005-10-14 Kompozicijos, turinčios lipazės, proteazės ir amilazės, skirtos kasos nepakankamumo gydymui LT2198880T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61876404P 2004-10-14 2004-10-14

Publications (1)

Publication Number Publication Date
LT2198880T true LT2198880T (lt) 2017-02-27

Family

ID=35840531

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP10158639.4T LT2198880T (lt) 2004-10-14 2005-10-14 Kompozicijos, turinčios lipazės, proteazės ir amilazės, skirtos kasos nepakankamumo gydymui

Country Status (24)

Country Link
US (1) US7718169B2 (lt)
EP (2) EP1809320B1 (lt)
JP (1) JP4908420B2 (lt)
KR (1) KR101333664B1 (lt)
CN (1) CN101068565B (lt)
AT (1) ATE474592T1 (lt)
AU (1) AU2005295754B2 (lt)
BR (1) BRPI0516515B1 (lt)
CA (1) CA2584069C (lt)
CY (2) CY1110838T1 (lt)
DE (1) DE602005022471D1 (lt)
DK (2) DK1809320T3 (lt)
ES (2) ES2352086T3 (lt)
HK (1) HK1109068A1 (lt)
HR (1) HRP20161684T1 (lt)
HU (1) HUE031245T2 (lt)
LT (1) LT2198880T (lt)
MX (1) MX2007004534A (lt)
PL (2) PL2198880T3 (lt)
PT (2) PT1809320E (lt)
RU (1) RU2385736C2 (lt)
SI (2) SI2198880T1 (lt)
UA (1) UA91521C2 (lt)
WO (1) WO2006044529A1 (lt)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
PT1729797E (pt) 2004-03-22 2008-12-17 Solvay Pharm Gmbh Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos
WO2006002453A2 (en) * 2004-07-07 2006-01-12 Biodevelops Pharma Entwicklung Gmbh Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
AU2006274835B2 (en) 2005-07-29 2012-05-24 Abbott Laboratories Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US8071089B2 (en) * 2005-11-01 2011-12-06 Bio-Cat, Inc. Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2008079685A2 (en) 2006-12-21 2008-07-03 Novozymes A/S Lipase variants for pharmaceutical use
US20080199448A1 (en) * 2007-02-16 2008-08-21 Ross Mairi R Enzyme composition for improving food digestion
RU2445952C2 (ru) * 2007-02-20 2012-03-27 Юранд Фармасьютикалз Лимитед Стабильные композиции пищеварительных ферментов
US8221747B2 (en) 2007-02-20 2012-07-17 Aptalis Pharma Limited Stable pancreatic enzyme compositions
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) * 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
ES2732453T3 (es) 2008-07-01 2019-11-22 Curemark Llc Métodos y composiciones para el tratamiento de síntomas de trastornos neurológicos y de salud mental
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
WO2010025126A1 (en) * 2008-08-26 2010-03-04 Cystic Fibrosis Foundation Therapeutics, Inc. Rapidly disintegrating tablets comprising lipase, amylase, and protease
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
US20110171294A1 (en) * 2008-09-30 2011-07-14 Dsm Ip Assets B.V. Enzyme composition and application thereof in the treatment of pancreatic insufficiency
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
AU2010203714C1 (en) * 2009-01-06 2013-12-12 Galenagen, Llc Compositions and methods for the treatment or the prevention of infections by e. coli
CN105664144B (zh) * 2009-01-06 2020-08-11 加尔纳根有限责任公司 治疗或预防金黄色葡萄球菌感染以及根除或减少表面上金黄色葡萄球菌的组合物和方法
AU2015252099B2 (en) * 2009-01-06 2017-08-10 Galenagen, Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
DK2391382T3 (da) * 2009-01-29 2014-08-25 Nordmark Arzneimittel Gmbh & Co Kg Farmaceutisk præparat indeholdende lipase af bakteriel oprindelse
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2010130622A1 (en) * 2009-05-11 2010-11-18 Dsm Ip Assets B.V. Enzyme composition for the treatment of prancreatic insufficiency
PL2295039T5 (pl) 2009-08-28 2023-02-27 Nordmark Pharma Gmbh Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę
AU2016216662B2 (en) * 2009-09-17 2017-09-07 Allergan Therapeutics LLC Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
US8784884B2 (en) 2009-09-17 2014-07-22 Stephen Perrett Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
CA2783342A1 (en) * 2009-12-08 2011-06-16 Depomed, Inc. Gastric retentive pharmaceutical compositions for extended release of polypeptides
JP2011162491A (ja) * 2010-02-10 2011-08-25 Ezaki Glico Co Ltd 乾燥麹抽出物及びこれを用いた口腔用組成物
SE535296C2 (sv) * 2010-09-08 2012-06-19 Anara Ab Mognad av mag-tarmkanalen
KR101968457B1 (ko) 2010-10-01 2019-04-11 앨러간 파마슈티컬스 인터내셔널 리미티드 장용 코팅된 저 강도 췌장 리파제 제제
FR2966734B1 (fr) 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
PL2489349T3 (pl) 2011-02-17 2014-09-30 Nordmark Arzneimittel Gmbh & Co Kg Granulki pankreatynowe, zwłaszcza mikrogranulki pankreatynowe, oraz sposób ich produkcji
AU2012245287B2 (en) 2011-04-21 2017-04-13 Curemark, Llc Compounds for the treatment of neuropsychiatric disorders
MX351014B (es) 2011-08-08 2017-09-28 Aptalis Pharma Ltd Metodo para la prueba de disolucion de composiciones solidas que contienen enzimas digestivas.
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
KR102186932B1 (ko) 2012-02-17 2020-12-07 알크레스타, 인크. 식이 지방산 수요를 공급하기 위한 방법들, 조성물들 및 디바이스들
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
AU2013318686B2 (en) 2012-09-19 2017-11-30 Grespo Ab Compositions for improvement of brain function
CA2905159C (en) 2013-03-15 2023-01-03 Aptalis Pharma Ltd. Composition containing digestive enzymes and nutrients suitable for enteral administration
US9861681B2 (en) 2013-04-18 2018-01-09 The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases Therapeutic compositions for neutralizing type I interferons, and methods of use
AU2014304176A1 (en) 2013-07-22 2016-02-11 Aptalis Pharma Ltd. High potency pancreatin pharmaceutical compositions
JP2016537387A (ja) 2013-08-09 2016-12-01 アラガン ファーマシューティカルズ インターナショナル リミテッド 経腸投与に適した消化酵素組成物
CN106659773A (zh) 2013-11-05 2017-05-10 阿勒根制药国际有限公司 高效的胰酶药物组合物
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
CA2947998A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
JP6797107B2 (ja) 2015-03-02 2020-12-09 東レ株式会社 膵臓機能異常の検出方法及び検出用キット
DE102015114859A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Verwendung einer pharmazeutischen Zusammensetzung, enthaltend mindestens ein Verdauungsenzym, bei der künstlichen Ernährung
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
DE102017104472A1 (de) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
US11045396B2 (en) 2017-08-17 2021-06-29 Alcresta Therapeutics, Inc. Devices and methods for the supplementation of a nutritional formula
FR3079146B1 (fr) 2018-03-23 2020-04-17 Karim Ioualalen Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive.
US11547745B1 (en) * 2018-08-23 2023-01-10 Vets Plus, Inc. Compositions and methods for treating pancreatic enzyme deficiencies in mammals
US11987823B2 (en) 2019-08-30 2024-05-21 Societe Des Produits Nestle S.A. Engineered lipase variants
US20230138700A1 (en) * 2020-03-30 2023-05-04 Jai WALL Combined animal-derived and synthetically produced pancreatic enzyme replacement therapy
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
AU2022356455A1 (en) * 2021-09-30 2024-04-11 Anagram Therapeutics, Inc. Engineered lipase enzymes, manufacture and use thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5017559B2 (lt) 1972-09-20 1975-06-21
JPS5428820Y2 (lt) 1974-06-14 1979-09-14
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4659667A (en) 1985-02-26 1987-04-21 Miles Laboratories, Inc. Process to recover crystalline enzymes and crystalline enzymes produced thereby
DK154572C (da) 1985-08-07 1989-04-24 Novo Industri As Enzymatisk detergentadditiv, detergent og fremgangsmaade til vask af tekstiler
JP3079276B2 (ja) 1988-02-28 2000-08-21 天野製薬株式会社 組換え体ｄｎａ、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法
DE3808695A1 (de) 1988-03-16 1989-10-05 Henkel Kgaa Fluessiges waschmittel
ES2059986T3 (es) 1989-03-08 1994-11-16 Simon Lodewijk Scharpe Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion.
ATE94206T1 (de) 1989-12-21 1993-09-15 Novo Nordisk As Enzymhaltige zubereitung und eine solche zubereitung enthaltendes detergens.
DK173590D0 (da) 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
SK283185B6 (sk) 1990-08-03 2003-03-04 Vertex Pharmaceuticals Incorporated Zosietené kryštály proteínov, zariadenie ich obsahujúce a ich použitie
US5892013A (en) 1990-09-13 1999-04-06 Novo Nordisk A/S Lipase variants
WO1993000924A1 (de) 1991-07-01 1993-01-21 Basf Aktiengesellschaft Verwendung von lipasen zur herstellung von arzneimitteln
WO1993013200A1 (en) 1991-12-20 1993-07-08 Novo Nordisk A/S A process for the preparation of lipase
AU672986B2 (en) 1992-06-30 1996-10-24 Cortecs Limited Use of enzymes, especially bromelain, in the treatment of diarrhoea
DK154292D0 (da) 1992-12-23 1992-12-23 Novo Nordisk As Nyt enzym
DK39693D0 (da) 1993-04-02 1993-04-02 Novo Nordisk As Enzym
GB9403344D0 (en) 1994-02-22 1994-04-13 Cortecs Ltd Medical application of bromelain
DE4408152A1 (de) 1994-03-11 1995-09-14 Studiengesellschaft Kohle Mbh Immobilisierte Lipasen in hydrophoben Sol-Gel-Materialien
DE69528524T2 (de) 1994-05-04 2003-06-26 Genencor International, Inc. Lipasen mit verbesserten tensiostabilitaet
WO1996038170A1 (en) 1995-05-31 1996-12-05 Medzyme N.V. Composition to improve digestibility and utilisation of nutrients
US5932212A (en) 1996-05-24 1999-08-03 Altus Biologics, Inc. Crosslinked protein crystal formulations and their use as catalysts in organic solvents
US5750104A (en) 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
US6140475A (en) 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
DK1009759T3 (da) 1997-09-05 2008-08-04 Altus Pharmaceuticals Inc Carbohydrat-tværbundne glycoproteinkrystaller
US6013680A (en) 1997-10-21 2000-01-11 Amano Pharmaceutical Co., Ltd. Digestive enzyme-containing medicament
WO1999055310A1 (en) 1998-04-27 1999-11-04 Altus Biologics Inc. Stabilized protein crystals, formulations containing them and methods of making them
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US6156552A (en) 1998-02-18 2000-12-05 Novo Nordisk A/S Lipase variants
US6042823A (en) 1998-07-02 2000-03-28 Amano Pharmaceuticals Co., Ltd. Enzyme composition and use thereof
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.

Also Published As

Publication number Publication date
SI1809320T1 (sl) 2010-11-30
US20060121017A1 (en) 2006-06-08
MX2007004534A (es) 2007-11-08
ES2352086T3 (es) 2011-02-15
JP4908420B2 (ja) 2012-04-04
PT1809320E (pt) 2010-10-25
PT2198880T (pt) 2017-01-04
KR101333664B1 (ko) 2013-11-28
CN101068565A (zh) 2007-11-07
RU2007117728A (ru) 2008-11-20
KR20070074622A (ko) 2007-07-12
WO2006044529A1 (en) 2006-04-27
HK1109068A1 (en) 2008-05-30
HUE031245T2 (en) 2017-06-28
UA91521C2 (ru) 2010-08-10
BRPI0516515B1 (pt) 2018-05-29
DK1809320T3 (da) 2010-11-15
PL1809320T3 (pl) 2011-11-30
AU2005295754B2 (en) 2010-09-09
DK2198880T3 (en) 2017-01-23
EP2198880B1 (en) 2016-11-23
AU2005295754A2 (en) 2010-09-02
DE602005022471D1 (de) 2010-09-02
CY1118597T1 (el) 2017-07-12
US7718169B2 (en) 2010-05-18
BRPI0516515A (pt) 2008-09-16
EP1809320B1 (en) 2010-07-21
ATE474592T1 (de) 2010-08-15
CA2584069A1 (en) 2006-04-27
EP1809320A1 (en) 2007-07-25
EP2198880A1 (en) 2010-06-23
HRP20161684T1 (hr) 2017-02-24
CA2584069C (en) 2017-02-07
CY1110838T1 (el) 2015-06-10
SI2198880T1 (sl) 2017-02-28
RU2385736C2 (ru) 2010-04-10
AU2005295754A1 (en) 2006-04-27
CN101068565B (zh) 2010-11-17
JP2008516965A (ja) 2008-05-22
PL2198880T3 (pl) 2017-04-28
ES2614157T3 (es) 2017-05-29

Similar Documents

Publication Publication Date Title
PL2198880T3 (pl) Kompozycje zawierające lipazę, proteazę i amylazę do leczenia niewydolności trzustki
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
WO2006024018A3 (en) Compositions for treating nociceptive pain
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
MX2010007564A (es) Composiciones de limpieza y/o tratamiento.
TW200714283A (en) Method and composition for treating peripheral vascular diseases
DE60330161D1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
TW200740804A (en) Glucokinase activators
MX342128B (es) Compuestos farmaceuticos.
IS2882B (is) Samsetning epóþílonhliðstæðna og virkra efna til efnameðferðar til þess að meðhöndla frumufjölgunarsjúkdóma
PL1779858T3 (pl) Zastosowanie związków selenu, w szczególności drożdży selenowych, do zmieniania funkcji poznawczych
MY148985A (en) 2-aminopyridine analogs as glucokinase activators
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
HK1118719A1 (en) Chromatin remodeling agents for increasing expression of pdx-1 and promoting cell differentiation
ZA200705177B (en) Lyophilization of virosomes
MX2009012920A (es) Compuestos heptaciclicos y usos farmaceuticos de los mismos para la prevencion y tratamiento de diabetes y sindrome metabolico.
WO2006069253A3 (en) Trefoil factors and methods of treating proliferation disorders using same
TW200716088A (en) Formulations and methods for treating amyloidosis
EP1879591B8 (en) Use of azapaullones for preventing and treating pancreatic autoimmune disorders
HK1102626A1 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
EP1866409A4 (en) TRANSPLANTATION OF PARATHYROIDS AND THYMUS IN SUBJECTS AFFECTED BY DIGEORGE SYNDROME
EA200601392A1 (ru) Способы и композиции для лечения липодистрофии
RS55450B1 (sr) Kompozicije koje sadrže lipazu, proteazu i amilazu za lečenje pankreatične insuficijencije